As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Hi, I am Amanda, an ordinary woman who is 45 years old. I am writing this review for you if you are struggling with unusual ...

It gets tricky fast': benefits lawyer outlines legal pitfalls of HR offering – or not offering – weight loss drugs in Canada ...

“I’m making money to afford semagultide,” Rice, 42, who works three jobs to afford the expensive injectables, explained to her over 14,000 TikTok fans . Classified as a GLP-1, appetite-suppressing ...

If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...

Progressive Grocer talks to Danone North America’s yogurt president about opportunities across formats and dayparts ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...